Trulieve Introduces New Brand Portfolio for Adult-Use and Medical Markets

3.3 min readPublished On: August 12th, 2021By

TALLAHASSEE, Fla., – Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States, today announced the launch of a comprehensive brand portfolio that includes four distinct brands designed to meet the needs of all consumers. With the addition of the Muse™, Sweet Talk™ and Momenta™ brands and the expansion of the Cultivar Collection™, the company is providing a range of  brands that together meet the full spectrum of consumer motivations and need-states. Trulieve’s evolving house of brands highlights the opportunity for all consumers to “live their best life” via curated products.

“We are pleased to offer our consumers new cannabis brands that support their journey and unlock the potential in all of us. We set out to create a broad line of products and brand identities that provide a variety of options for every day and every occasion,” said Valda Coryat, Trulieve Chief Marketing Officer. “At Trulieve, we focus on continuous innovation with the intent to exceed expectations and elevate the consumer experience.”

The full Cultivar Collection including Muse, Momenta, and Sweet Talk will be available in the Massachusetts market, where the new brands have been introduced at the company’s Northampton location. The Cultivar Collection launched in Florida in October 2020, and is one of Trulieve’s fastest selling products. Pending regulatory approvals, the full suite of brands will be available in Trulieve’s additional operating markets in the coming months.

Forward-Looking Statements

This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company and statements with regard to the Report and the Company’s response thereto. Words such as “expects”, “continue”, “will”, “anticipates” and “intends” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on the Company’s current projections and expectations about future events and financial trends that management believes might affect its financial condition, results of operations, business strategy and financial needs, and on certain assumptions and analysis made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors management believes are appropriate. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein, including, without limitation, the risks discussed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 and in subsequent periodic and current reports filed with the United States Securities and Exchange Commission and in the Company’s filings on SEDAR at www.sedar.com. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.                         

(This information is primarily sourced from Trulieve Cannabis Corp.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: News Team

Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News

  • CBD Oil Market, CBD Skin Care Market, Industrial hemp Market, Medical Marijuana Market, Financial Results

CBD Oil Market to Register 31.50% CAGR by 2031

December 3rd, 2022|

NEWARK, Del - The global cannabidiol CBD oil market is anticipated to grow at an impressive compound annual growth rate (CAGR) of 31.50% annually over the projection period from 2021 to 2031. The global market ...